← SynDRA
Ro-10-5824
SynDRA canonical compound SYN0087021 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DRD4 |
|---|
| Mechanism of action | Dopamine receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Dopamine receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRB2
- ATXN2
- BLM
- CBX1
- DRD2
- EHMT2
- GLS
- HDAC6
- KCNH2
- KDM4E
- LMNA
- MPHOSPH8
- MTOR
- OPRM1
- PMP22
- TARDBP
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ADA10
- ALR
- DRD3
- HS90A
- HS90B
- NTM1A
Cross-references
Synonyms
- Ro10-5824
- 8X35VUU4YY
- Ro 10-5824
- UNII-8X35VUU4YY
- SCHEMBL5021445
- SCHEMBL29380689
- CHEBI:93407
- KABDATZAOUSYES-UHFFFAOYSA-N
- BDBM50608789
- AKOS040749347
- BRD-K79684402-300-01-0
- BRD-K79684402-300-02-8
- 2-methyl-5-[(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methyl]-4-pyrimidinamine
- Ro10-5824;Ro-10-5824
- PHA74494
- HY-101384A
- C17H22Cl2N4
- SB57963
- T12761
- DA-67249
- UNII-4ZF8VEB9K3
- AKOS024457053
- SCHEMBL7802182
- orb1309150
- Ro10-58242HCl
- D80673
- Ro 10-5824 dihydrochloride
- EX-A3784
- CS-7578
- BS-15854
- NCGC00092373-01
- Ro 10-5824 2HCl
- Ro 10-5824 (dihydrochloride)
- 4ZF8VEB9K3
Look up Ro-10-5824 in the interactive SynDRA portal →